Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MID1IP1 antisense RNA 1 (MID1IP1-AS1) is a human long non-coding RNA (lncRNA) gene transcribed from the strand opposite the protein-coding MID1IP1 gene. As an antisense RNA, its function is presumed to involve regulation of gene expression—typically by hybridizing to the corresponding sense mRNA or modulating chromatin status at the locus—but there are no direct functional or mechanistic studies on MID1IP1-AS1 itself in the current literature. Unlike MID1IP1 (a protein), MID1IP1-AS1 does not encode a protein product and is not recognized as a classic therapeutic target such as a receptor, enzyme, or transporter. There are no known disease associations, drug interactions, or validated biomarker roles for this lncRNA as of this writing, and its biological significance remains to be elucidated.
Not applicable (no drugs known to target this lncRNA)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MID1IP1 antisense RNA 1 (MID1IP1-AS1).